Lina Concierge Med Spa Review: Resolve the Cancellation Terms Before Enrolling

The most consequential number in Lina Concierge Med Spa’s public documentation may not be its $139 monthly starting price. It may be the difference between 30 days and 48 hours. Treatment pages require 30 days’ notice before the next billing cycle to cancel, while the terms describe turning off automatic refills up to 48 hours before monthly processing. Those are materially different instructions for someone deciding whether another payment will occur. Neither should be treated as the settled rule without written clarification.

Lina advertises a fully remote service offering compounded semaglutide and tirzepatide, alongside oral and microdose GLP-1 programs and other therapies. Its appeal is a coordinated package: clinical evaluation, medication, portal messaging and home delivery. This documentary review examines what enrolling appears to authorize, who carries each responsibility and where the promises need more precision. Public pages were consulted October 19, 2026; professional credentials and licensing statements are reported as the site’s claims, not independent verification.

At a glance

Conflicting cancellation deadlines: Treatment pages require 30 days’ notice; the terms allow cancellation through the portal up to 48 hours before monthly processing.
Sources: [11] [6]
Recurring billing: Recurring monthly orders authorize an immediate charge and another every 30 days until cancellation, with electronic notice 5–7 days before a scheduled transaction.
Sources: [6]
Advertised GLP-1 starting prices: The catalog lists semaglutide injection from $139/month, tirzepatide injection from $166/month, GLP-1 Microdose from $199/month and GLP-1 Oral from $229/month.
Sources: [10]
Separate service responsibilities: Lina describes itself as a platform, not the entity practicing medicine, prescribing or dispensing; independent practitioners and pharmacies perform those functions.
Sources: [7]
Pharmacy restriction: The terms require purchasers of prescription-inclusive services to waive choosing a pharmacy outside the platform’s arrangements.
Sources: [6]

Cancellation is the first unresolved enrollment condition

Lina’s treatment-page policy says memberships may be canceled with 30 days’ notice before the next billing cycle. Its terms instead say a subscription can be canceled up to 48 hours before the applicable monthly processing date by switching off auto-refill in the user portal. The consulted documentation does not reconcile these provisions. A reader cannot safely assume that the shorter deadline overrides the longer one, or that switching off refills necessarily satisfies every membership requirement.

Before authorizing a recurring order, request a written answer identifying the controlling deadline, the next processing date and whether a separate membership remains active after auto-refill is disabled. Ask whether cancellation affects an order already being prepared. Our guide to cancellation notice and order status explains why stopping future renewals and stopping a current pharmacy order are different questions. Saving the response and the portal confirmation would create a clearer record than relying on a general marketing statement.

There is a separate refund boundary. Lina says consultations, medical visits and fulfilled prescriptions are nonrefundable once services begin or medication is processed. Cancellation therefore should not be read as a promise to return an earlier payment. The homepage also promises no charge if a program is not the right fit. The missing detail is how that promise interacts with immediate recurring-order billing and the point at which a service becomes nonrefundable.

Sources: [11] [6] [7]

The contracting party needs a clearer name

The brand attributes its founding to Melissa Linares, NP, and presents her as a board-certified acute care nurse practitioner. Those are published credentials, not findings from a licensing investigation. More importantly for enrollment, the site says Lina is a concierge telehealth platform facilitating access to independent U.S.-licensed practitioners and state-licensed compounding pharmacies. It explicitly says the platform does not practice medicine, write prescriptions or dispense pharmaceuticals. A branded experience therefore does not mean one organization performs every service.

The terms introduce another identity question. Their initial arbitration notice names Lina Concierge Med Spa, LLC, while other clauses use Melissa Caramanica Nurse Practitioner in Acute Care PLLC. The relationship between those names is not explained in the consulted passages. That inconsistency does not establish wrongdoing, but it makes identifying the contracting entity, billing contact and responsible clinical organization more important before payment. The available terms also contain an omitted middle section, limiting conclusions about the agreement as a whole.

Ask for the legal name of the platform seller, the medical group responsible for the consultation and the pharmacy expected to dispense the prescription. These names should be distinguishable on the agreement, receipts and care records. Our guide to platform, clinician and pharmacy responsibilities offers a framework for that conversation. Lina’s public documentation does not identify the dispensing pharmacies or the medical group assigned to each state, so those details remain enrollment questions.

Sources: [8] [7] [6] [11]

Starting prices do not settle the purchase terms

Lina documents actual starting prices, rather than requiring readers to complete an intake before seeing any amount. Its homepage says plans start at $139 per month, with the price confirmed after provider review. The catalog separates injection, microdose and oral offerings, but the brief listings do not establish supply quantities, minimum commitments or complete conditions for qualifying for those prices. The oral listing does not name its active ingredient; the microdose documentation does not establish its ingredient, formulation or route.

Treatment pages advertise flat-rate programs without hidden fees, unexpected consultation charges or dose-change surcharges. The terms describe a bundled price comprising pharmacy charges, medical-group services and platform access. Those statements help explain the package but do not replace an individualized quote. Ask for the exact product, formulation, route, quantity, total charge and renewal terms in writing. A guide to reading a written GLP-1 quote can help distinguish a documented inclusion from an assumption.

The catalog is broader than weight-management injections: it also advertises tesamorelin from $299 monthly, sermorelin from $249, NAD+ from $146 and PT-141 from $249. These are separate advertised offerings, not documented inclusions in the GLP-1 price. Lina identifies NAD+ as a coenzyme rather than a peptide. None of those listings establishes that adding another therapy would preserve the original GLP-1 bundle price.

Advertised GLP-1 prices and the details still needed
Catalog offering	Advertised starting price	Important boundary
Semaglutide injection	From $139/month	Supply quantity and full starting-price conditions are not specified.
Tirzepatide injection	From $166/month	The listing does not establish quantity or minimum commitment.
GLP-1 Microdose	From $199/month	Ingredient, formulation and route are not established.
GLP-1 Oral	From $229/month	The catalog describes daily oral use but does not identify the active ingredient.

Sources: [10] [7] [11] [6]

The payment clock runs every 30 days

For a recurring monthly order, Lina’s terms authorize charging the listed amount immediately and every 30 days afterward until cancellation. That is a specific interval, not necessarily the same date in each calendar month. The terms promise electronic notification five to seven days before a scheduled transaction and a receipt after a successful charge. Readers should ask which date controls cancellation: the payment-processing date, a membership renewal date or another date displayed in the portal.

The documentation does not establish a separate introductory-versus-renewal price schedule, required upfront multi-month payment or an optional installment arrangement. Nor does a monthly label establish a one-month minimum commitment. Lina’s flat-rate promise addresses consultation surprises and dose-change surcharges, but it should not be expanded into an indefinite price-lock guarantee. The practical task is to obtain the confirmed first charge and subsequent charge, including any circumstances under which the amount could change.

Lina says insurance is not required. That does not answer whether it accepts insurance, submits claims or permits HSA/FSA payment; those points are not resolved in the consulted material. Shipping is listed among the program features, but a separate shipping charge is not specified. Before checkout, compare the final total with the written inclusions rather than interpreting missing fee information as proof that every related expense is covered.

Sources: [6] [11] [7]

Online enrollment is not prescription approval

Lina advertises an online assessment covering medical history, goals and baseline measurements, with an estimated completion time of five to ten minutes. That estimate describes the intake form, not clinical review or approval. The terms require a consultation, a practitioner’s determination that the product is appropriate and an issued prescription before a prescription product can be obtained. Despite the homepage’s no-appointments language, readers should clarify what consultation format their state and proposed treatment require.

The platform advertises service in all 50 states and says there is no physical office to visit. Its terms nevertheless require users to be physically in the same state as their account’s shipping address during consultation, and availability remains subject to state rules. Users must be at least 18, or the age of majority where they reside if higher. Nationwide advertising therefore does not guarantee access to every product from any location or while traveling.

The semaglutide page describes candidates as adults with BMI of at least 27, or at least 25 with weight-related conditions; tirzepatide publishes the same thresholds. Semaglutide exclusions include personal or family medullary thyroid carcinoma or MEN 2, pregnancy, breastfeeding, pregnancy planning, active pancreatitis and untreated severe gastrointestinal disease. These are Lina’s published screening criteria, not an individual eligibility determination. The microdose page targets a different audience and excludes people whose remaining weight-loss needs would be better served by a standard program.

Sources: [11] [6] [12] [5] [7]

Pharmacy choice and delivery deserve their own questions

Lina’s terms make pharmacy routing a material enrollment condition: purchasers of a prescription-inclusive service waive having the prescription filled at a pharmacy of their choice. Anyone expecting to move the prescription to a local pharmacy should resolve that issue before purchasing. The treatment page says U.S.-licensed compounding pharmacies prepare its protocols, but the consulted passage does not name them. The terms also state that prescription products will not be dispensed in child-resistant containers, a detail worth addressing before delivery.

The semaglutide program describes compounded medication shipped on a structured cadence, with temperature-controlled, unmarked packaging delivered to the home. It does not establish clinical-review, preparation, dispatch or arrival deadlines, identify a carrier or explain a temperature-incident process. Ask who handles delayed, damaged or inadequately refrigerated packages and whether replacement costs apply. FDA explicitly advises not using an injectable GLP-1 product that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy.

Lina acknowledges that compounded medications are not FDA approved. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence, but pharmacy licensing does not confer FDA approval on a preparation. Published drug trials also do not establish outcomes for Lina’s particular compounded formulations, oral offering or microdose program. Contract clarity and clinical evidence answer different questions.

Sources: [7] [11] [6] [1] [2] [3]

Ongoing support is described, but not fully scheduled

The semaglutide program advertises a dedicated practitioner, direct messaging through a secure patient portal and recurring concierge check-ins. The homepage says follow-ups are scheduled as needed to adjust the plan. These are meaningful service descriptions, but they do not establish a minimum visit frequency, guaranteed practitioner response time or a complete monitoring schedule. Requirements and costs for laboratory testing are also unspecified. Ask what follow-up is included and what happens if an additional evaluation is needed.

For general contact, Lina publishes info@linaconciergemedspa.com, portal access and support hours Monday through Saturday, 9 a.m. to 6 p.m. Eastern. Its contact form advertises a team response within 24 hours. That is not a documented clinical-review deadline, delivery promise or guarantee of an immediate prescribing response. Separating administrative support from practitioner messaging would help patients know where to send cancellation requests, billing disputes, medication questions and shipment concerns without assuming every channel serves the same purpose.

Sources: [7] [11] [9]

Privacy promises need to be read alongside the terms

Lina markets its intake as secure and HIPAA compliant, including encrypted storage of patient intake information. Its terms add an important distinction: Lina says it is not itself a HIPAA covered entity, although it may act as a business associate of a pharmacy or medical group in some circumstances. Those statements are not necessarily mutually exclusive, but the marketing phrase alone does not explain which organization holds each record or which rules govern every website interaction.

There is a more direct tension between the treatment FAQ’s broad no-selling-or-sharing assurance and the California notice. That notice says certain personal information may be disclosed to third parties for advertising and that these disclosures may count as a sale or sharing under California law. The consulted material does not resolve the scope of each statement. Before submitting sensitive information, ask which data categories are involved, what choices are available and how marketing data is separated from clinical records.

These questions belong before enrollment, not only after a billing or privacy concern develops. Reviewing the terms that deserve a closer read can help organize requests for clarification. Lina could make the decision materially easier by publishing one consistent cancellation rule, explaining its legal entities and distinguishing clinical privacy protections from advertising practices. Until then, written answers are more useful than assuming the broadest assurance controls every part of the service.

Sources: [7] [11] [6] [4]

Questions & answers

Can I cancel Lina two days before the next charge?

The terms describe cancellation up to 48 hours before monthly processing by disabling auto-refill. Treatment pages instead require 30 days’ notice before the next billing cycle. Because the documentation does not identify which rule prevails, obtain written confirmation before relying on the shorter deadline. Cancellation also does not automatically create a refund right.

Sources: [6] [11]

Is the advertised $139 price guaranteed for my program?

No. It is the advertised starting price for semaglutide injection, and the homepage says pricing is confirmed after provider review. Treatment pages promise flat-rate pricing without dose-change surcharges, but the consulted documentation does not establish your supply quantity, full starting-price conditions or an indefinite price lock. Request the first and recurring charges in writing.

Sources: [10] [7] [11]

Will Lina charge me if a practitioner declines treatment?

The homepage says patients are never charged if a program is not the right fit. Separately, recurring-order terms authorize immediate charging, and treatment pages restrict refunds once services begin or medication is processed. Ask when eligibility is determined relative to payment and what happens to any payment authorization if no prescription is issued.

Sources: [7] [6] [11]

Can I use my own pharmacy?

The terms say purchasing a prescription-inclusive service requires waiving pharmacy choice outside the platform’s arrangements. They instruct people who do not want to waive that choice not to purchase the service. The consulted treatment passage describes licensed U.S. compounding pharmacies but does not name them; request the dispensing pharmacy’s identity before enrollment.

Sources: [6] [11]

Does Lina’s 50-state coverage let me consult while traveling?

Not necessarily. Although Lina advertises all-state telehealth, the terms require being physically in the same state as the shipping address in your account during consultation. Availability also depends on state-specific rules. Contact the service before arranging a consultation while away; nationwide marketing is not confirmation that a particular consultation or product is available wherever you are.

Sources: [11] [6]

What ongoing contact does the program advertise?

The semaglutide page advertises a dedicated practitioner, secure portal messaging between check-ins and periodic reviews. General support is listed Monday through Saturday, 9 a.m.–6 p.m. Eastern, with a 24-hour contact-form response claim. The documentation does not establish a guaranteed clinical response time, minimum review frequency or laboratory-testing schedule and cost.

Sources: [11] [9]

Our assessment

Lina documents an appealing service structure: visible GLP-1 starting prices, bundled medication and care, practitioner messaging and temperature-controlled home delivery. It also acknowledges the platform’s limited role and the unapproved status of compounded preparations. Those disclosures provide a useful starting point, not a complete enrollment agreement. The conflicting cancellation deadlines are the most immediate financial concern, followed by unclear contractual identities, unnamed dispensing partners and privacy statements that need reconciliation. Before paying, obtain one written explanation of the controlling cancellation rule, exact recurring charge, refund trigger, responsible medical group and dispensing pharmacy. Readers comfortable with a platform-arranged pharmacy and remote care may find the offering worth further inquiry, but the unresolved terms prevent a confident conclusion about how easily a patient can exit or recover a disputed payment. Clearer documentation would improve the service’s assessability without proving anything about individual treatment results.

Visit Lina Concierge Med Spa’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Lina Concierge Med Spa Review: Resolve the Cancellation Terms Before Enrolling

At a glance

01Cancellation is the first unresolved enrollment condition

02The contracting party needs a clearer name

03Starting prices do not settle the purchase terms

04The payment clock runs every 30 days

05Online enrollment is not prescription approval

06Pharmacy choice and delivery deserve their own questions

07Ongoing support is described, but not fully scheduled

08Privacy promises need to be read alongside the terms